Table 1 Proportions of “HDM-only” patients using the indicated medications during each questionnaire period (2012)
2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Late May | Early June | Late June | Early July | Late July | Early Aug. | Late Aug. | Early Sept. | Late Sept. | Early Oct. | Late Oct. | Early Nov. | Late Nov. | Early Dec. | Late Dec. | |
Antihistamines | 41% | 45% | 42% | 42% | 43% | 47% | 47% | 41% | 45% | 38% | 36% | 41% | 44% | 40% | 46% |
Nasal corticoids | 14% | 14% | 15% | 13% | 16% | 9% | 16% | 20% | 12% | 10% | 14% | 17% | 13% | 16% | 13% |
Inhaled corticoids | 1% | 1% | 1% | – | 1% | – | – | – | – | 5% | – | 1% | 3% | – | 2% |
Bronchodilators | 5% | 1% | 6% | 2% | 5% | 12% | 5% | 7% | 6% | 5% | 5% | 4% | 7% | 5% | – |
Inhaled corticoid + bronchodilator | 1% | 3% | 2% | 5% | 6% | 5% | 7% | 12% | 3% | 6% | 3% | 1% | 4% | 5% | 4% |
Other corticoids | 4% | – | 4% | 7% | 6% | 5% | 2% | – | – | 4% | 2% | – | 4% | 2% | 8% |
Eye drops | 3% | 3% | 5% | 4% | 3% | 5% | 5% | 2% | 9% | 5% | 8% | 10% | 7% | 8% | 6% |
Leukotriene receptor antagonist | 3% | 3% | 2% | 4% | 3% | 2% | 5% | 2% | 6% | 3% | 3% | 1% | 3% | 3% | 2% |
Nasal decongestants | 5% | 3% | 6% | 12% | 6% | 2% | 4% | – | 3% | 6% | 9% | 9% | 3% | 8% | 2% |
Other anti-H1 | 4% | 4% | 1% | 2% | 1% | 5% | – | – | 3% | 1% | 3% | 3% | 3% | – | – |
Other nasal sprays | 7% | 3% | 4% | 1% | 3% | 2% | 2% | 7% | 6% | 3% | 3% | 1% | 1% | 3% | 2% |
Cromone | – | 1% | – | – | – | – | – | – | – | – | – | – | – | – | – |
Cough syrups | 1% | 1% | 1% | – | – | 2% | – | – | -+ | – | – | – | 1% | – | – |
Pain killers | – | 1% | 1% | 1% | – | 2% | – | 5% | – | 3% | 3% | 1% | 1% | 3% | 6% |
Antimigraine drugs | 1% | 4% | 1% | 1% | – | – | – | – | – | – | – | – | – | – | – |
Homeopathy | – | – | – | – | – | – | – | – | – | – | – | 1% | – | – | 2% |
Antibiotics | 3% | 3% | 2% | 1% | 1% | – | – | – | – | 1% | 2% | – | 1% | – | – |
Other | 7% | 5% | 6% | 4% | 0% | 7% | 4% | 2% | 6% | 10% | 13% | 7% | 4% | 6% | 8% |